| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |